{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:32Z","timestamp":1793061332460,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018841","name":"Associazione Italiana Ricerca Alzheimer","doi-asserted-by":"publisher","award":["2023 Armenise Harvard-AIRALZH Mid-Career Award in Neurodegenerative Diseases - AHA MCA"],"award-info":[{"award-number":["2023 Armenise Harvard-AIRALZH Mid-Career Award in Neurodegenerative Diseases - AHA MCA"]}],"id":[{"id":"10.13039\/501100018841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2022 PNRR P2022R2E8N"],"award-info":[{"award-number":["PRIN2022 PNRR P2022R2E8N"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ID853981"],"award-info":[{"award-number":["ID853981"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006781","name":"Giovanni Armenise-Harvard Foundation for Scientific Research Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102918","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:55:38Z","timestamp":1787068538000},"page":"102918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["GLP-1 receptor agonists for Alzheimer\u2019s disease: Lessons from trials and translational challenges"],"prefix":"10.1016","volume":"7","author":[{"given":"Ramona","family":"Stringhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0452-762X","authenticated-orcid":false,"given":"Elena","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102918_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2026.102918_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14283\/jpad.2022.21","article-title":"Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with anti-amyloid beta therapy","volume":"9","author":"Barakos","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.xcrm.2026.102918_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107770","article-title":"Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges","volume":"216","author":"Zhou","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2026.102918_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102918_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1515\/jtim-2025-0026","article-title":"Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists","volume":"13","author":"Feng","year":"2025","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.xcrm.2026.102918_bib11","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(26)00459-9","article-title":"Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer\u2019s disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials","volume":"407","author":"Cummings","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102918_bib12","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1212\/WNL.0000000000211162","article-title":"Investigating the effects of semaglutide in early Alzheimer\u2019s disease using single-cell transcriptomics and proteomics \u2013 rationale and design (P12-3.017)","volume":"104","author":"Mystkowski","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.xcrm.2026.102918_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111898","article-title":"A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk \u2013 study rationale and design","volume":"218","author":"Davidy","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.xcrm.2026.102918_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer's disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xcrm.2026.102918_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","article-title":"Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial","volume":"32","author":"Edison","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102918_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1567205016666190913155950","article-title":"A pilot study of exenatide actions in Alzheimer's disease","volume":"16","author":"Mullins","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.xcrm.2026.102918_bib7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s40618-024-02320-7","article-title":"Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial","volume":"47","author":"Dei Cas","year":"2024","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.xcrm.2026.102918_bib10","doi-asserted-by":"crossref","first-page":"8661","DOI":"10.1002\/alz.14313","article-title":"Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: target trial emulation using nationwide real-world data in the US","volume":"20","author":"Wang","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xcrm.2026.102918_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14556","article-title":"The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer\u2019s disease","volume":"21","author":"Padovani","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.xcrm.2026.102918_bib15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:22:07Z","timestamp":1793060527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003356"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102918","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists for Alzheimer\u2019s disease: Lessons from trials and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102918"}}